Universe Pharmaceuticals INC (UPC)
| Market Cap | 1.58M +9.1% |
| Revenue (ttm) | 17.86M -22.4% |
| Net Income | -3.67M |
| EPS | -8.06 |
| Shares Out | 563.34K |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,491 |
| Open | 2.890 |
| Previous Close | 3.000 |
| Day's Range | 2.760 - 2.890 |
| 52-Week Range | 2.000 - 11.000 |
| Beta | 1.58 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jan 29, 2026 |
About UPC
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshit... [Read more]
Full Company ProfileFinancial Performance
In fiscal year 2025, UPC's revenue was $17.86 million, a decrease of -22.44% compared to the previous year's $23.02 million. Losses were -$3.67 million, -57.92% less than in 2024.
Financial StatementsNews
Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure
Ji'an, Jiangxi, China, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, t...
Universe Pharmaceuticals Inc trading resumes
09:39 EDT Universe Pharmaceuticals (UPC) Inc trading resumes
Universe Pharmaceuticals Inc trading halted, volatility trading pause
09:34 EDT Universe Pharmaceuticals (UPC) Inc trading halted, volatility trading pause
Universe Pharmaceuticals Inc trading halted, news pending
19:50 EDT Universe Pharmaceuticals (UPC) Inc trading halted, news pending
Universe Pharmaceuticals INC Announces Share Consolidation
Jiangxi, China, March 20, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today a...
Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report
Ji'an, Jiangxi, China, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that on Februar...
Universe Pharmaceuticals gets Nasdaq delisting notice
Universe Pharmaceuticals (UPC) announced that the company received a letter from the Nasdaq Stock Market on January 29 notifying the company that the Nasdaq staff has determined to delist the
Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request
Ji'an, Jiangxi, China, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Compan...
Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)
New York, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, tod...
Universe Pharmaceuticals to sell 18.75M shares at 80c in direct offering
Universe Pharmaceuticals (UPC) has entered into a definitive agreement with several investors for the purchase and sale of an aggregate of 18,750,000 of the Company’s ordinary share, par value $0.2812...
Universe Pharmaceuticals Inc trading halted, news pending
19:50 EST Universe Pharmaceuticals (UPC) Inc trading halted, news pending
Universe Pharmaceuticals announces share consolidation
Universe Pharmaceuticals (UPC) announced that the Company plans to effect a share consolidation of 15 ordinary shares with par value of US$0.01875 per share each in the Company’s issued and
Universe Pharmaceuticals receives Nasdaq notification over bid price deficiency
Universe Pharmaceuticals (UPC) announced that the Company received a written notification from the Nasdaq Stock Market LLC on October 25, 2024, notifying the Company that it is not in compliance
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Ji'an, Jiangxi, China, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Compan...
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024
JI'AN, Jiangxi, China, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company,” “we,” “our” and “us”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today an...
Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results
JI'AN, China, Jan. 30, 2024 /PRNewswire/ -- Universe Pharmaceuticals INC ("Universe Pharmaceuticals" or the "Company") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announce...
Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares
Jiangxi, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today an...
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022
JI'AN, China, Aug. 16, 2022 /PRNewswire/ -- Universe Pharmaceuticals INC (the "Company") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial resu...
Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce Platforms
Ji'an, Jiangxi, China, March 30, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Compa...
Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese Medicine
Ji'an, Jiangxi, China, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Compan...
Universe Pharmaceuticals INC Appoints Mr. Baochang Liu as Chief Operating Officer
Ji'an, Jiangxi, China, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Compan...
Universe Pharmaceuticals INC Announces Strategic Alliance with Kitanihon Pharmaceutical Co., Ltd. to Address the Market Demand for Kampo Medicine and High-end Traditional Chinese Medicine
Ji'an, Jiangxi, China, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that on Decembe...
Universe Pharmaceuticals INC to Announce Unaudited Financial Results for The First Six Months of Fiscal Year 2021 on August 2, 2021
Ji'an, Jiangxi, China, July 30, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that it will re...
Universe Pharmaceuticals INC Announces Full Exercise of Underwriter's Over-Allotment Option in the Public Offering
Ji'an, Jiangxi, China, March 31, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the underwrite...
Universe Pharmaceuticals INC Announces Closing of Initial Public Offering
Ji'an, Jiangxi, China, March 25, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the closing of...